Structure

Physi-Chem Properties

Molecular Weight:  540.2
Volume:  525.612
LogP:  1.81
LogD:  0.853
LogS:  -4.551
# Rotatable Bonds:  6
TPSA:  149.57
# H-Bond Aceptor:  10
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.431
Synthetic Accessibility Score:  6.118
Fsp3:  0.586
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.374
MDCK Permeability:  1.7085507352021523e-05
Pgp-inhibitor:  0.994
Pgp-substrate:  0.247
Human Intestinal Absorption (HIA):  0.813
20% Bioavailability (F20%):  0.997
30% Bioavailability (F30%):  0.98

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.73
Plasma Protein Binding (PPB):  85.77635192871094%
Volume Distribution (VD):  1.7
Pgp-substrate:  13.290863990783691%

ADMET: Metabolism

CYP1A2-inhibitor:  0.067
CYP1A2-substrate:  0.34
CYP2C19-inhibitor:  0.725
CYP2C19-substrate:  0.166
CYP2C9-inhibitor:  0.797
CYP2C9-substrate:  0.02
CYP2D6-inhibitor:  0.044
CYP2D6-substrate:  0.032
CYP3A4-inhibitor:  0.931
CYP3A4-substrate:  0.535

ADMET: Excretion

Clearance (CL):  1.8
Half-life (T1/2):  0.398

ADMET: Toxicity

hERG Blockers:  0.177
Human Hepatotoxicity (H-HT):  0.852
Drug-inuced Liver Injury (DILI):  0.318
AMES Toxicity:  0.55
Rat Oral Acute Toxicity:  0.994
Maximum Recommended Daily Dose:  0.848
Skin Sensitization:  0.183
Carcinogencity:  0.939
Eye Corrosion:  0.003
Eye Irritation:  0.008
Respiratory Toxicity:  0.982

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469576

Natural Product ID:  NPC469576
Common Name*:   Moluccensin H
IUPAC Name:   n.a.
Synonyms:   Moluccensin H
Standard InCHIKey:  IGHHWHRZZGJKOP-CCDRIMESSA-N
Standard InCHI:  InChI=1S/C29H32O10/c1-14(30)38-24-26(3)13-28(34)27(4,18(26)11-19(31)36-5)16-6-8-25(2)17(21(16)22(33)29(24,28)35)10-20(32)39-23(25)15-7-9-37-12-15/h7,9-10,12,18,23-24,34-35H,6,8,11,13H2,1-5H3/t18-,23-,24-,25+,26-,27+,28+,29+/m0/s1
SMILES:  COC(=O)C[C@H]1[C@]2(C)C[C@]3([C@]1(C)C1=C(C(=O)[C@]3([C@H]2OC(=O)C)O)C2=CC(=O)O[C@H]([C@@]2(CC1)C)c1ccoc1)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1088035
PubChem CID:   46184327
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001553] Triterpenoids
          • [CHEMONTID:0002380] Limonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. PMID[20112995]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[20146503]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds Thai n.a. PMID[21733687]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[22724531]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota seeds n.a. n.a. PMID[26114936]
NPO6445 Xylocarpus moluccensis Species Meliaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT845 Cell Line BT-474 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[546018]
NPT65 Cell Line HepG2 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[546018]
NPT323 Cell Line SW-620 Homo sapiens IC50 > 10.0 ug.mL-1 PMID[546018]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 10.0 ug.mL-1 PMID[546018]
NPT2 Others Unspecified IC50 > 27000.0 nM PMID[546019]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469576 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9938 High Similarity NPC469633
0.9632 High Similarity NPC94763
0.9632 High Similarity NPC236004
0.9398 High Similarity NPC478177
0.9277 High Similarity NPC471437
0.9268 High Similarity NPC327922
0.9259 High Similarity NPC165218
0.9207 High Similarity NPC478179
0.9146 High Similarity NPC478178
0.9059 High Similarity NPC470938
0.8929 High Similarity NPC285227
0.8929 High Similarity NPC159232
0.8922 High Similarity NPC472765
0.8922 High Similarity NPC472766
0.8896 High Similarity NPC472778
0.8896 High Similarity NPC472776
0.8896 High Similarity NPC472777
0.8869 High Similarity NPC472659
0.8862 High Similarity NPC472764
0.8802 High Similarity NPC149945
0.8795 High Similarity NPC469338
0.8795 High Similarity NPC292389
0.8793 High Similarity NPC247563
0.8793 High Similarity NPC242068
0.878 High Similarity NPC261597
0.878 High Similarity NPC36655
0.8773 High Similarity NPC44675
0.8773 High Similarity NPC214541
0.875 High Similarity NPC173516
0.875 High Similarity NPC476224
0.8743 High Similarity NPC470940
0.8743 High Similarity NPC469849
0.8743 High Similarity NPC276551
0.8735 High Similarity NPC329938
0.8735 High Similarity NPC82851
0.8727 High Similarity NPC475967
0.872 High Similarity NPC469485
0.8713 High Similarity NPC471632
0.8698 High Similarity NPC471397
0.869 High Similarity NPC470875
0.869 High Similarity NPC214600
0.869 High Similarity NPC472141
0.8686 High Similarity NPC105395
0.8683 High Similarity NPC224394
0.8683 High Similarity NPC663
0.8675 High Similarity NPC477402
0.8667 High Similarity NPC470118
0.8667 High Similarity NPC187149
0.8667 High Similarity NPC173544
0.8659 High Similarity NPC264943
0.8655 High Similarity NPC469848
0.8647 High Similarity NPC470995
0.8639 High Similarity NPC472774
0.8639 High Similarity NPC472775
0.8623 High Similarity NPC472767
0.8623 High Similarity NPC188649
0.8623 High Similarity NPC6326
0.8623 High Similarity NPC472668
0.8623 High Similarity NPC69028
0.8623 High Similarity NPC149896
0.8614 High Similarity NPC477403
0.8614 High Similarity NPC475226
0.8614 High Similarity NPC474932
0.8613 High Similarity NPC470181
0.8588 High Similarity NPC160651
0.8588 High Similarity NPC271235
0.8571 High Similarity NPC472773
0.8571 High Similarity NPC88841
0.8571 High Similarity NPC471168
0.8571 High Similarity NPC472669
0.8571 High Similarity NPC288602
0.8571 High Similarity NPC477405
0.8563 High Similarity NPC470789
0.8563 High Similarity NPC472653
0.8554 High Similarity NPC249021
0.8554 High Similarity NPC197137
0.8554 High Similarity NPC299038
0.8554 High Similarity NPC45101
0.8554 High Similarity NPC195131
0.8545 High Similarity NPC155939
0.8545 High Similarity NPC296807
0.8545 High Similarity NPC141538
0.8537 High Similarity NPC44577
0.8529 High Similarity NPC472651
0.8521 High Similarity NPC271657
0.8521 High Similarity NPC470182
0.8512 High Similarity NPC5079
0.8512 High Similarity NPC470792
0.8512 High Similarity NPC472771
0.8512 High Similarity NPC5741
0.8512 High Similarity NPC200782
0.8512 High Similarity NPC471166
0.8512 High Similarity NPC471167
0.8512 High Similarity NPC197596
0.8512 High Similarity NPC18347
0.8503 High Similarity NPC307383
0.8503 High Similarity NPC472779
0.8497 Intermediate Similarity NPC477824
0.8494 Intermediate Similarity NPC204663
0.8488 Intermediate Similarity NPC169299
0.8488 Intermediate Similarity NPC160818
0.848 Intermediate Similarity NPC472652
0.8462 Intermediate Similarity NPC134254
0.8462 Intermediate Similarity NPC39986
0.8462 Intermediate Similarity NPC234660
0.8462 Intermediate Similarity NPC51568
0.8462 Intermediate Similarity NPC472139
0.8462 Intermediate Similarity NPC302369
0.8452 Intermediate Similarity NPC25255
0.8443 Intermediate Similarity NPC286722
0.8443 Intermediate Similarity NPC88007
0.8434 Intermediate Similarity NPC92979
0.843 Intermediate Similarity NPC82602
0.843 Intermediate Similarity NPC472650
0.8424 Intermediate Similarity NPC33938
0.8424 Intermediate Similarity NPC469503
0.8424 Intermediate Similarity NPC246164
0.8424 Intermediate Similarity NPC476201
0.8421 Intermediate Similarity NPC476850
0.8421 Intermediate Similarity NPC472282
0.8421 Intermediate Similarity NPC476861
0.8415 Intermediate Similarity NPC470997
0.8412 Intermediate Similarity NPC123088
0.8412 Intermediate Similarity NPC476858
0.8412 Intermediate Similarity NPC476856
0.8412 Intermediate Similarity NPC259943
0.8412 Intermediate Similarity NPC476857
0.8402 Intermediate Similarity NPC193798
0.8402 Intermediate Similarity NPC68848
0.8402 Intermediate Similarity NPC263432
0.8393 Intermediate Similarity NPC475295
0.8393 Intermediate Similarity NPC473473
0.8393 Intermediate Similarity NPC472671
0.8383 Intermediate Similarity NPC209364
0.8382 Intermediate Similarity NPC475237
0.8382 Intermediate Similarity NPC475641
0.8373 Intermediate Similarity NPC98206
0.8373 Intermediate Similarity NPC34421
0.8373 Intermediate Similarity NPC253201
0.8373 Intermediate Similarity NPC30222
0.8373 Intermediate Similarity NPC237259
0.8373 Intermediate Similarity NPC282445
0.8373 Intermediate Similarity NPC302054
0.8372 Intermediate Similarity NPC296558
0.8372 Intermediate Similarity NPC472673
0.8364 Intermediate Similarity NPC18135
0.8364 Intermediate Similarity NPC116717
0.8363 Intermediate Similarity NPC121995
0.8354 Intermediate Similarity NPC69647
0.8354 Intermediate Similarity NPC472654
0.8354 Intermediate Similarity NPC234494
0.8354 Intermediate Similarity NPC471001
0.8354 Intermediate Similarity NPC125182
0.8353 Intermediate Similarity NPC285567
0.8353 Intermediate Similarity NPC469846
0.8344 Intermediate Similarity NPC255414
0.8343 Intermediate Similarity NPC335761
0.8343 Intermediate Similarity NPC191828
0.8333 Intermediate Similarity NPC194499
0.8333 Intermediate Similarity NPC472772
0.8333 Intermediate Similarity NPC214495
0.8333 Intermediate Similarity NPC475066
0.8333 Intermediate Similarity NPC470119
0.8333 Intermediate Similarity NPC167142
0.8333 Intermediate Similarity NPC195954
0.8333 Intermediate Similarity NPC472283
0.8323 Intermediate Similarity NPC35000
0.8323 Intermediate Similarity NPC469336
0.8323 Intermediate Similarity NPC471175
0.8323 Intermediate Similarity NPC476262
0.8314 Intermediate Similarity NPC476853
0.8313 Intermediate Similarity NPC472672
0.8313 Intermediate Similarity NPC268905
0.8313 Intermediate Similarity NPC470996
0.8304 Intermediate Similarity NPC261184
0.8304 Intermediate Similarity NPC476860
0.8303 Intermediate Similarity NPC156189
0.8303 Intermediate Similarity NPC196846
0.8294 Intermediate Similarity NPC18986
0.8294 Intermediate Similarity NPC211777
0.8294 Intermediate Similarity NPC117986
0.8294 Intermediate Similarity NPC96443
0.8294 Intermediate Similarity NPC290400
0.8294 Intermediate Similarity NPC470939
0.8274 Intermediate Similarity NPC175964
0.8274 Intermediate Similarity NPC471169
0.8274 Intermediate Similarity NPC107646
0.8274 Intermediate Similarity NPC126723
0.8263 Intermediate Similarity NPC178932
0.8263 Intermediate Similarity NPC57998
0.8256 Intermediate Similarity NPC93172
0.8256 Intermediate Similarity NPC97574
0.8256 Intermediate Similarity NPC23387
0.8256 Intermediate Similarity NPC475779
0.8253 Intermediate Similarity NPC272590
0.8246 Intermediate Similarity NPC283209
0.8246 Intermediate Similarity NPC198047
0.8242 Intermediate Similarity NPC470998
0.8242 Intermediate Similarity NPC195325
0.8239 Intermediate Similarity NPC262386

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469576 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8545 High Similarity NPD5761 Phase 2
0.8545 High Similarity NPD5760 Phase 2
0.8212 Intermediate Similarity NPD8434 Phase 2
0.8129 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD6764 Approved
0.7933 Intermediate Similarity NPD6765 Approved
0.776 Intermediate Similarity NPD6785 Approved
0.776 Intermediate Similarity NPD6784 Approved
0.7322 Intermediate Similarity NPD7799 Discontinued
0.7288 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7287 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7075 Discontinued
0.7216 Intermediate Similarity NPD6599 Discontinued
0.7171 Intermediate Similarity NPD8404 Phase 2
0.7151 Intermediate Similarity NPD3817 Phase 2
0.7135 Intermediate Similarity NPD6801 Discontinued
0.7127 Intermediate Similarity NPD919 Approved
0.711 Intermediate Similarity NPD7236 Approved
0.7095 Intermediate Similarity NPD7819 Suspended
0.7074 Intermediate Similarity NPD6559 Discontinued
0.7074 Intermediate Similarity NPD7685 Pre-registration
0.7045 Intermediate Similarity NPD920 Approved
0.7006 Intermediate Similarity NPD7239 Suspended
0.7 Intermediate Similarity NPD7497 Discontinued
0.6994 Remote Similarity NPD4628 Phase 3
0.6973 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6971 Remote Similarity NPD6799 Approved
0.6961 Remote Similarity NPD5402 Approved
0.6957 Remote Similarity NPD8127 Discontinued
0.6957 Remote Similarity NPD1247 Approved
0.6952 Remote Similarity NPD3818 Discontinued
0.6932 Remote Similarity NPD642 Clinical (unspecified phase)
0.6923 Remote Similarity NPD3882 Suspended
0.6923 Remote Similarity NPD7879 Clinical (unspecified phase)
0.6902 Remote Similarity NPD5494 Approved
0.6898 Remote Similarity NPD7473 Discontinued
0.6893 Remote Similarity NPD6273 Approved
0.6891 Remote Similarity NPD8150 Discontinued
0.6865 Remote Similarity NPD7199 Phase 2
0.6854 Remote Similarity NPD5403 Approved
0.6836 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6836 Remote Similarity NPD5401 Approved
0.6833 Remote Similarity NPD4380 Phase 2
0.6831 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6825 Remote Similarity NPD7804 Clinical (unspecified phase)
0.6821 Remote Similarity NPD5762 Approved
0.6821 Remote Similarity NPD5763 Approved
0.6818 Remote Similarity NPD643 Clinical (unspecified phase)
0.6813 Remote Similarity NPD2393 Clinical (unspecified phase)
0.68 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6793 Remote Similarity NPD3749 Approved
0.6793 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6788 Remote Similarity NPD8407 Phase 2
0.6771 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6758 Remote Similarity NPD1934 Approved
0.6755 Remote Similarity NPD6166 Phase 2
0.6755 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6755 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6742 Remote Similarity NPD2532 Approved
0.6742 Remote Similarity NPD2534 Approved
0.6742 Remote Similarity NPD2533 Approved
0.674 Remote Similarity NPD7028 Phase 2
0.6738 Remote Similarity NPD6232 Discontinued
0.6737 Remote Similarity NPD5844 Phase 1
0.6724 Remote Similarity NPD6005 Phase 3
0.6724 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6724 Remote Similarity NPD6002 Phase 3
0.6724 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6724 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6724 Remote Similarity NPD6004 Phase 3
0.6721 Remote Similarity NPD2801 Approved
0.6719 Remote Similarity NPD8368 Discontinued
0.6719 Remote Similarity NPD7251 Discontinued
0.6714 Remote Similarity NPD7907 Approved
0.6703 Remote Similarity NPD7411 Suspended
0.6702 Remote Similarity NPD3926 Phase 2
0.6685 Remote Similarity NPD8443 Clinical (unspecified phase)
0.6685 Remote Similarity NPD3226 Approved
0.6684 Remote Similarity NPD3751 Discontinued
0.6684 Remote Similarity NPD7808 Phase 3
0.6667 Remote Similarity NPD2796 Approved
0.6667 Remote Similarity NPD6234 Discontinued
0.6667 Remote Similarity NPD6797 Phase 2
0.6667 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6651 Remote Similarity NPD5619 Clinical (unspecified phase)
0.665 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6649 Remote Similarity NPD7057 Phase 3
0.6649 Remote Similarity NPD7058 Phase 2
0.6649 Remote Similarity NPD4965 Approved
0.6649 Remote Similarity NPD8313 Approved
0.6649 Remote Similarity NPD7054 Approved
0.6649 Remote Similarity NPD8312 Approved
0.6649 Remote Similarity NPD4966 Approved
0.6649 Remote Similarity NPD4967 Phase 2
0.6648 Remote Similarity NPD2800 Approved
0.6648 Remote Similarity NPD1243 Approved
0.6648 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6629 Remote Similarity NPD1471 Phase 3
0.6628 Remote Similarity NPD6355 Discontinued
0.662 Remote Similarity NPD4111 Phase 1
0.662 Remote Similarity NPD4665 Approved
0.6615 Remote Similarity NPD7472 Approved
0.6615 Remote Similarity NPD7074 Phase 3
0.6611 Remote Similarity NPD1512 Approved
0.661 Remote Similarity NPD3750 Approved
0.6591 Remote Similarity NPD970 Clinical (unspecified phase)
0.6585 Remote Similarity NPD7435 Discontinued
0.6576 Remote Similarity NPD37 Approved
0.6561 Remote Similarity NPD3787 Discontinued
0.6556 Remote Similarity NPD7410 Clinical (unspecified phase)
0.6554 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6534 Remote Similarity NPD2346 Discontinued
0.6532 Remote Similarity NPD5735 Approved
0.652 Remote Similarity NPD4107 Approved
0.6514 Remote Similarity NPD2799 Discontinued
0.6514 Remote Similarity NPD3748 Approved
0.6514 Remote Similarity NPD7033 Discontinued
0.651 Remote Similarity NPD7228 Approved
0.6509 Remote Similarity NPD5647 Approved
0.6508 Remote Similarity NPD6959 Discontinued
0.6503 Remote Similarity NPD7458 Discontinued
0.65 Remote Similarity NPD1511 Approved
0.6497 Remote Similarity NPD1549 Phase 2
0.6494 Remote Similarity NPD6653 Approved
0.6492 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6488 Remote Similarity NPD4482 Phase 3
0.6484 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6482 Remote Similarity NPD8360 Approved
0.6482 Remote Similarity NPD8361 Approved
0.6482 Remote Similarity NPD8435 Approved
0.6477 Remote Similarity NPD1551 Phase 2
0.6477 Remote Similarity NPD6099 Approved
0.6477 Remote Similarity NPD6100 Approved
0.6471 Remote Similarity NPD7768 Phase 2
0.6456 Remote Similarity NPD3057 Approved
0.6456 Remote Similarity NPD2972 Approved
0.6456 Remote Similarity NPD3533 Approved
0.6453 Remote Similarity NPD2313 Discontinued
0.6452 Remote Similarity NPD1465 Phase 2
0.6441 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6441 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6439 Remote Similarity NPD6782 Approved
0.6439 Remote Similarity NPD6779 Approved
0.6439 Remote Similarity NPD6780 Approved
0.6439 Remote Similarity NPD6776 Approved
0.6439 Remote Similarity NPD6777 Approved
0.6439 Remote Similarity NPD6781 Approved
0.6439 Remote Similarity NPD6778 Approved
0.6425 Remote Similarity NPD7893 Clinical (unspecified phase)
0.642 Remote Similarity NPD1510 Phase 2
0.6412 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6406 Remote Similarity NPD2403 Approved
0.64 Remote Similarity NPD7048 Phase 3
0.6398 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6398 Remote Similarity NPD7874 Approved
0.6389 Remote Similarity NPD6190 Approved
0.6387 Remote Similarity NPD7315 Approved
0.6387 Remote Similarity NPD7229 Phase 3
0.6379 Remote Similarity NPD4140 Approved
0.6378 Remote Similarity NPD7240 Approved
0.6377 Remote Similarity NPD2491 Approved
0.6373 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6358 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6348 Remote Similarity NPD2344 Approved
0.6346 Remote Similarity NPD7696 Phase 3
0.6346 Remote Similarity NPD7697 Approved
0.6346 Remote Similarity NPD7698 Approved
0.6343 Remote Similarity NPD447 Suspended
0.6337 Remote Similarity NPD6832 Phase 2
0.6333 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6333 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6333 Remote Similarity NPD4110 Phase 3
0.6331 Remote Similarity NPD7078 Approved
0.6324 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6322 Remote Similarity NPD6663 Approved
0.6322 Remote Similarity NPD8032 Phase 2
0.6319 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6316 Remote Similarity NPD8320 Phase 1
0.6316 Remote Similarity NPD8319 Approved
0.6316 Remote Similarity NPD7870 Phase 2
0.6316 Remote Similarity NPD7871 Phase 2
0.6308 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6307 Remote Similarity NPD6353 Approved
0.6307 Remote Similarity NPD6651 Approved
0.6303 Remote Similarity NPD7701 Phase 2
0.6302 Remote Similarity NPD5710 Approved
0.6302 Remote Similarity NPD5711 Approved
0.6301 Remote Similarity NPD7095 Approved
0.63 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6298 Remote Similarity NPD3448 Approved
0.6293 Remote Similarity NPD8485 Approved
0.6292 Remote Similarity NPD2935 Discontinued
0.6291 Remote Similarity NPD5676 Approved
0.6291 Remote Similarity NPD7801 Approved
0.6286 Remote Similarity NPD7966 Clinical (unspecified phase)
0.6265 Remote Similarity NPD6319 Approved
0.6264 Remote Similarity NPD6798 Discontinued
0.6264 Remote Similarity NPD3268 Approved
0.6262 Remote Similarity NPD8462 Phase 1
0.6257 Remote Similarity NPD1049 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data